April 2026 Edition

Biotech Signal Report

Our AI's top 10 biotech trading signals for April 2026 — with FDA catalyst analysis, insider trading patterns, and conviction scores for every pick.

Get Instant Access — $9→

One-time purchase • Instant access • No subscription

What's Inside

01
Executive Summary
Market regime & sector outlook
02
Top 10 Biotech Signals
Full AI analysis with conviction scores
03
FDA Catalyst Calendar
April 2026 PDUFA dates & AdCom meetings
04
Insider Trading Patterns
Form 4 cluster analysis & anomalies
05
Position Sizing Guide
Risk-adjusted entry & exit framework
> signal_preview

Preview: Top 3 Signals

Full analysis for all 10 signals available in the report

#01VRTXVertex PharmaceuticalsSTRONG BUY
Catalyst: Phase III pain data readout + NDA submission expected
Unusual insider accumulation detected in Form 4 filings. NLP analysis of Q4 earnings call reveals management confidence language scoring 94th percentile. PDUFA date April 18 creates binary catalyst.
Conviction: 96/100Entry: $412 – $425Target: $480+Timeframe: 2–4 weeks
#02MRNAModerna Inc.BUY
Catalyst: RSV vaccine data + combo respiratory program
SEC 10-K reveals accelerating pipeline diversification. AI detected positive sentiment shift in institutional 13-F filings — 14 new positions opened in Q4. FDA advisory committee scheduled April 9.
Conviction: 91/100Entry: $38 – $42Target: $52+Timeframe: 3–6 weeks
#03BMRNBioMarin PharmaceuticalBUY
Catalyst: ROCTAVIAN gene therapy uptake inflection
Form 4 analysis shows C-suite buying at 18-month high. Revenue recognition patterns in 10-Q suggest upcoming beat. European commercial launch gaining traction per regulatory filings.
Conviction: 89/100Entry: $72 – $78Target: $92+Timeframe: 4–8 weeks
#04████STRONG BUY
FDA breakthrough therapy designation pending...
Conviction: 93/100
#05████BUY
Insider cluster buying + Phase II data catalyst...
Conviction: 90/100
#06████SELL
Negative Form 4 pattern + dilution risk detected...
Conviction: 87/100
#07████BUY
M&A target profile — unusual options activity...
Conviction: 86/100
#08████STRONG BUY
PDUFA date + positive AdCom vote probability...
Conviction: 85/100
#09████BUY
Gene therapy commercial inflection point...
Conviction: 83/100
#10████SELL
Patent cliff + pipeline gap detected in 10-K...
Conviction: 81/100
Unlock All 10 Signals

Get the full report with detailed analysis, entry/exit prices, FDA calendar, and insider trading patterns.

Buy Report — $9→Secure checkout via Stripe • Instant access

What's in the Report

📊

10 AI-Ranked Signals

Each with ticker, direction, conviction score, entry/exit range, and full AI reasoning chain.

🧬

FDA Catalyst Calendar

Every PDUFA date, AdCom meeting, and regulatory milestone for April 2026 that could move biotech stocks.

🔍

Insider Trading Patterns

Form 4 cluster analysis showing unusual buying/selling from executives and directors.

📐

Position Sizing Guide

Risk-adjusted sizing framework so you know exactly how much to allocate per signal.

Ready to Trade with an Edge?

One report. Ten signals. All the data you need to trade biotech this month.

Get Instant Access — $9→

Want signals every day? Upgrade to Pro ($99/year)